Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales

The Journal of Antimicrobial Chemotherapy
Nicola C ElvissKenneth Davies

Abstract

Surveillance data on Helicobacter pylori antibiotic susceptibilities in Wales are limited, despite resistance being a key factor in treatment failure. A single-centre survey was undertaken over 3 years to determine local antibiotic resistance rates on isolates from dyspeptic patients in Bangor, Gwynedd (North Wales). Susceptibilities were determined for 363 isolates by disc diffusion and the Etest. Isolates were also genotyped (cagA presence and vacA allelic types). Overall in vitro resistance rates were 24% for metronidazole and 7% for clarithromycin, with 4% resistant to both antibiotics. Resistant strains typically had high MICs of >256 mg/L. Tetracycline resistance was identified in only one isolate whereas no isolates showed resistance to amoxicillin. There was a two-fold increase in resistance over the study period. No gender and age associations with resistance were detected. Resistant and susceptible isolates were genotypically diverse with respect to cagA/vacA type but the vacA s1m2 form was a feature of all clarithromycin-resistant isolates compared with 56% of the susceptible isolates. Although the overall antibiotic resistance rates of H. pylori from North Wales were low compared with many other regions in Europe, c...Continue Reading

Citations

Feb 17, 2009·Archivum Immunologiae Et Therapiae Experimentalis·Mitsushige Sugimoto, Yoshio Yamaoka
Feb 3, 2012·Journal of Clinical Gastroenterology·Seiji ShiotaYoshio Yamaoka
Dec 24, 2013·World Journal of Gastroenterology : WJG·Enzo IerardiMariabeatrice Principi
May 6, 2014·Journal of Pediatric Gastroenterology and Nutrition·Hamza KarabiberAli Ozer
Jul 20, 2010·Diagnostic Microbiology and Infectious Disease·Lyudmila BoyanovaIvan Mitov
Sep 24, 2015·Helicobacter·Bekir Kocazeybek, Hrisi Bahar Tokman
Mar 23, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Alba Edith VegaHumberto Jesús Silva
Jun 30, 2016·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Judit Alarcón-MillánAdolfo Román-Román
Dec 18, 2009·Expert Review of Anti-infective Therapy·Lyudmila Boyanova, Ivan Mitov
Mar 14, 2018·World Journal of Gastroenterology : WJG·Denise E BrennanSinéad M Smith
Jul 17, 2019·BMC Public Health·Kathleen WilliamsUNKNOWN CANHelp Working Group
Mar 29, 2005·Molecular and Cellular Biochemistry·Archana ChatterjeeSidney J Stohs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.